3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
52
Pancreatic Neoplasms
34
Colonic Neoplasms
20
Carcinoma, Hepatocellular
19
Esophageal Neoplasms
15
Neoplasms
14
Breast Neoplasms
12
Gastrointestinal Neoplasms
11
Stomach Neoplasms
10
Liver Neoplasms
10
Rectal Neoplasms
9
Lung Neoplasms
8
Head and Neck Neoplasms
7
Fibrosis
6
Biliary Tract Neoplasms
5
Ovarian Neoplasms
4
Neoplastic Cells, Circulating
4
Neoplasm, Residual
4
Neoplasm Metastasis
4
Gastrointestinal Stromal Tumors
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Pancreatic Cyst
3
Melanoma
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Cachexia
3
Sarcoma
2
Prostatic Neoplasms
2
Pancreatic Diseases
2
Interventions
Oxaliplatin
3
Fluorouracil
3
Radiotherapy
2
Immune Checkpoint Inhibitors
2
Endoscopy
2
Drug Therapy
2
Chemoradiotherapy
2
toripalimab
1
tislelizumab
1
pembrolizumab
1
X-Rays
1
Tretinoin
1
TP protocol
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proctectomy
1
Positron Emission Tomography Computed Tomography
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Immunotherapy
1
Immunohistochemistry
1
Esophagectomy
1
Epirubicin
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Docetaxel
1
Diffusion Magnetic Resonance Imaging
1
Cisplatin
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Blood Specimen Collection
×
Gastrointestinal
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled